Koios DS

by Koios Medical  · Based in United States → — Confident diagnosis in seconds. AI-based Clinical Decision Support for Radiologists.
Endocrinology Oncology Radiology

Subscription model: annual subscription pricing tailored to customer size.
Regulatory Status Disclosed

Overview

Koios DS is an AI-powered clinical decision support software developed by Koios Medical, designed to assist trained interpreting physicians in analyzing breast and thyroid ultrasound images. The software utilizes artificial intelligence and machine learning to provide real-time cancer risk assessments and classify lesions based on image data, aligning with established diagnostic systems like ACR BI-RADS, European U1-U5 Classification System, ACR TI-RADS, and American Thyroid Association (ATA) risk stratification systems. Koios DS aims to improve diagnostic accuracy, reduce interpretation variability, decrease unnecessary biopsies of benign tissue, and streamline clinical workflows. It can also function as an image viewer for multi-modality digital images, including ultrasound and mammography, and integrates seamlessly into most PACS workstations and directly onto ultrasound scanners.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-based clinical decision support for ultrasound images
  • Analysis of breast and thyroid ultrasound images
  • Automatic classification of lesions (BI-RADS, TI-RADS, European U1-U5, ATA)
  • AI/ML-derived cancer risk assessment
  • Auto-population of lesion/nodule descriptors
  • Lesion/nodule segmentation
  • Image viewer for multi-modality digital images (ultrasound, mammography)
  • Integrates with PACS workstations
  • Real-time decision making / instantaneous results (in seconds)
  • Exportable findings to reporting systems

Use Cases

  • Early detection and accurate diagnosis of breast cancer
  • Early detection and accurate diagnosis of thyroid cancer
  • Reducing unnecessary biopsies of benign tissue
  • Improving diagnostic accuracy and consistency for physicians
  • Streamlining workflow and reducing interpretation time
  • Prioritizing high-risk patients for backlog assessment

What Physicians Need to Know

Key Capabilities
Koios DS utilizes AI and machine learning to provide clinical decision support for breast and thyroid cancer detection and diagnosis from ultrasound images. It analyzes over 17,000 features per image from a proprietary dataset of over 2 million ultrasound images to classify lesions and assess cancer risk. The software provides malignancy risk assessments and standardized lesion descriptors aligned with BI-RADS for breast and TI-RADS/ATA for thyroid, aiming to reduce missed diagnoses and unnecessary biopsies.
Clinical Utility
Koios DS assists physicians in making more accurate and efficient diagnoses, potentially reducing benign biopsies by up to 20-55% and increasing cancer detection by up to 5-6%. It streamlines diagnostic workflows, saving time for physicians and sonographers, and supports standardized clinical reporting. The system is designed to provide an objective, data-driven assessment in seconds.
Integration Options
Koios DS integrates directly into existing clinical imaging workflows, including most PACS workstations and enterprise imaging viewers. It can export findings to reporting systems and save them as secondary captures to PACS. Collaborations exist with PACS vendors like AGFA, Change Healthcare, Fujifilm, GE Centricity, Sectra, and Visage Imaging, and reporting package integrations include 3M MModal, MagView, and PenRad. It is also available on the GE Healthcare LOGIQ™ E10 scanner.
Compliance Status
Koios DS is FDA-cleared and CE-marked. It holds multiple 510(k) clearances from the FDA for software that assesses lesions suspicious for cancer.
Pricing Model
Koios DS operates on a Software-as-a-Service (SaaS) model, generating recurring revenue through annual subscriptions for hospitals, health systems, and radiology groups. Pricing scales with usage, from individual physicians to full enterprise integrations. Subscriptions include reimbursement support, as commercial insurance companies reimburse providers for its use.
User Experience
The software is designed for simplicity, allowing users to select a region of interest by dragging an 'owl' icon or using 'Smart Click' for analysis. It provides feedback for diagnosis in seconds and aims to reduce manual data entry. The system is continuously improved based on feedback from physician customers.
Implementation Complexity
Implementation is designed to be rapid and seamless, involving downloading the software and configuring settings to the existing PACS or Enterprise Imaging viewer. No coding is required. Koios Medical works directly with hospital IT staff or PACS vendors for installation and configuration.
Evidence Base
Koios DS is clinically proven, with several published, peer-reviewed studies demonstrating improved physician performance in both specificity and sensitivity. Studies show it can reduce benign biopsies by 20-55% and increase cancer detection by up to 5-6%. Research has also indicated improved accuracy in breast cancer diagnosis for radiologists across all experience levels and a reduction in inter- and intraobserver variability.
Physician Tip

Koios DS serves as an AI-powered 'second opinion' for ultrasound images, providing objective, data-driven assessments for breast and thyroid lesions. It can significantly enhance diagnostic accuracy and efficiency, potentially reducing unnecessary biopsies and improving cancer detection rates. Integrate it into your existing PACS workflow for streamlined reporting and consider its utility for standardizing lesion assessments. Remember that Koios DS is an adjunct tool, and clinical judgment remains paramount. Ensure proper training for optimal utilization and to understand its output in alignment with BI-RADS or TI-RADS/ATA guidelines.

Koios DS is designed for seamless integration with most PACS and enterprise imaging systems, including major vendors like AGFA, Change Healthcare, Fujifilm, GE Centricity, Sectra, and Visage Imaging. It also integrates with popular reporting solutions such as 3M MModal, MagView, and PenRad. The software can be deployed directly on ultrasound scanners (e.g., GE Healthcare LOGIQ™ E10) or connected to any PACS, ensuring flexibility within diverse clinical environments. This broad compatibility aims to minimize technical complexity and integration costs for healthcare providers.

Details

Category Oncology AI, Radiology & Imaging AI
Pricing Subscription model: annual subscription pricing tailored to customer size.
DeploymentOn-premise (integrates with PACS and/or directly on ultrasound systems like GE Healthcare's LOGIQ™ E10 and Philips Ultrasound EPIC and Affiniti).
Mobile AppNo (not intended for use on portable handheld devices like smartphones or tablets).
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
GDPR Yes AI-estimated
Integrations
EHR Not specified
Specialties Endocrinology, Oncology, Radiology

Support & Reliability

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2024-11-15K242130 510(k)Koios DS

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Koios DS

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Koios DS.

View all on YouTube

Frequently Asked Questions

Koios DS is an AI-powered software that analyzes ultrasound images to help diagnose breast and thyroid cancer. It provides malignancy risk assessments and standardized lesion descriptors aligned with BI-RADS for breast and TI-RADS/ATA for thyroid, acting as a decision support tool for physicians.
Studies have shown that Koios DS can lead to a significant reduction in benign biopsies (up to 31-37%) while increasing diagnostic accuracy and sensitivity, potentially catching more cancers. It also aims to reduce interpretation time and inter- and intra-reader variability among physicians.
Yes, Koios DS Breast is FDA-cleared and CE-marked, indicating it meets regulatory standards for use in the US and Europe. Koios Medical maintains an effective quality management system to ensure ongoing product development, improvement, and regulatory compliance.
Koios DS is intended as an adjunct to diagnostic ultrasound examinations, and patient management decisions should not be made solely on its results. It is not intended for evaluating normal tissue, post-surgical excision sites, or images with Doppler, elastography, or other overlays.
Koios DS integrates seamlessly into most PACS workstations and supports DICOM protocol, allowing it to communicate smoothly with major PACS systems. It can also be installed directly on some ultrasound scanners, and results can be exported to reporting systems.
While Koios DS Breast is noted as an FDA-cleared solution for breast ultrasound image analysis, the field of AI in medical imaging is growing. Other AI solutions exist for various aspects of breast imaging, such as iCAD's ProFound AI Breast Health Suite for mammography.
Pricing for Koios DS is based on annual diagnostic exam volume, providing a software license for unlimited use by the entire physician and technologist staff. Commercial insurance companies reimburse providers for the use of this software, making it a billable procedure.

Related Tools

VERITON CT 400 Series Digital SPECT/CT System (VERITON CT 416/464)
Spectrum Dynamics Medical
Oncology AI
The VERITON CT 400 Series is a digital SPECT/CT system with a 360-degree gantry and 12 swiveling CZT detectors, offering high sensitivity and quantitative accuracy for a wide range of nuclear medicine applications, including advanced theranostics imaging.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
BIOGRAPH One
Siemens Healthineers AG
Oncology AI
BIOGRAPH One is a second-generation PET/MR scanner designed to transform PET/MR image quality for a new era, combining high PET precision with powerful MR performance. It enables simultaneous visualization of organ location, function, and cellular metabolism, offering faster image acquisition times and more efficient workflows than previous generations of PET/MR scanners.
Claire™ OCT System
Perimeter Medical Imaging AI
Oncology AI
Perimeter Medical Imaging AI is a medical technology company driven to transform cancer surgery with ultra-high resolution, real-time, advanced imaging tools that address unmet medical needs.S. for intraoperative breast cancer margin assessment.
syngo.via RT Image Suite VC10
Varian Medical Systems, Inc.
Clinical Decision Support & Reference
syngo.via RT Image Suite VC10 offers advanced imaging and workflow solutions for precise and efficient radiation therapy planning.

See all Oncology AI tools →

More in the Koios DS line

Koios DS (this page) Koios DS for Breast

More from Koios Medical

Koios DS for Breast
Koios Medical
Clinical Decision Support & Reference

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-08 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.